Skip to Main Content

The fight over the cost of medicines has erupted in yet another country as members of the Chilean congress have asked the government to sidestep patents on several treatments in hopes of widening access for their citizens.

In a petition delivered on Monday, the representatives and several patient advocacy groups asked Chilean health minister Carmen Castillo Taucher to issue compulsory licenses for the Xtandi prostate cancer therapy and several hepatitis C medicines sold by Gilead Sciences.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!